Syphilis is still a frequent sexually transmitted infection (STI) with very serious consequences not only for the index patient but sexual partners if the diagnosis is missed.


  1. Alexander JM, Sheffield JS, Sanchez PJ, et al. Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol. 1999;93:5–8.PubMedGoogle Scholar
  2. Association of Public Health Laboratories (APHL). Laboratory diagnostic testing for Treponema pallidum. Expert consultation meeting summary report, 13–15 Jan 2009, Atlanta. Available at:–Documents/LaboratoryGuidelinesTreponemapallidumMeetingReport.pdf.
  3. CDC. Inadvertent use of Bicillin® C-R to treat syphilis infection – Los Angeles, California, 1999–2004. MMWR Morb Mortal Wkly Rep. 2005;54:217–9.Google Scholar
  4. CDC. Symptomatic early neurosyphilis among HIV-positive men who have sex with men: four cities, United States, January 2002–June 2004. MMWR Morb Mortal Wkly Rep. 2007;56:625–8.Google Scholar
  5. CDC. Syphilis testing algorithms using treponemal tests for initial screening – four laboratories, New York City, 2005–2006. MMWR Morb Mortal Wkly Rep. 2008;57:872–5.Google Scholar
  6. CDC. Guidelines for the laboratory diagnosis of gonorrhea, chlamydia and syphilis. Available at:
  7. Dowell ME, Ross PG, Musher DM, et al. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med. 1992;93:481–8.CrossRefGoogle Scholar
  8. Ghanem KG. Sensitivity and specificity of lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms reply. Clin Infect Dis. 2009;49:162–3.CrossRefGoogle Scholar
  9. Ghanem KG, Erbelding EJ, Cheng WW, et al. Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin Infect Dis. 2006;42:e45–9.CrossRefGoogle Scholar
  10. Ghanem KG, Erbelding EJ, Wiener ZS, et al. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect. 2007;83:97–101.CrossRefGoogle Scholar
  11. Ghanem KG, Moore RD, Rompalo AM, et al. Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS. 2008a;22:1145–51.CrossRefGoogle Scholar
  12. Ghanem KG, Moore RD, Rompalo AM, et al. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clin Infect Dis. 2008b;47:258–65.CrossRefGoogle Scholar
  13. Hollier LM, Harstad TW, Sanchez PJ, et al. Fetal syphilis: clinical and laboratory characteristics. Obstet Gynecol. 2001;97:947–53.PubMedGoogle Scholar
  14. Hook III EW, Baker-Zander SA, Moskovitz BL, et al. Ceftriaxone therapy for asymptomatic neurosyphilis. Case report and Western blot analysis of serum and cerebrospinal fluid IgG response to therapy. Sex Transm Dis. 1986;13(3 Suppl):S185–8.CrossRefGoogle Scholar
  15. Hook III EW, Roddy RE, Handsfield HH. Ceftriaxone therapy for incubating and early syphilis. J Infect Dis. 1988;158:881–4.CrossRefGoogle Scholar
  16. Hook III EW, Martin DH, Stephens J, et al. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis. 2002;29:486–90.CrossRefGoogle Scholar
  17. Hook III EW, Behets F, Van DK, et al. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis. 2010;201:1729–35.CrossRefGoogle Scholar
  18. Jaffe HW, Larsen SA, Peters M, et al. Tests for treponemal antibody in CSF. Arch Intern Med. 1978;138:252–5.CrossRefGoogle Scholar
  19. Janier M, Hegyi V, Dupin N, et al. European guidelines on the management of syphilis. JEADV. 2014;28:1581–93.Google Scholar
  20. Kingston AA, Vujevich J, Shapiro M, et al. Seronegative secondary syphilis in 2 patients coinfected with human immunodeficiency virus. Arch Dermatol. 2005;141:431–3.CrossRefGoogle Scholar
  21. Klein VR, Cox SM, Mitchell MD, et al. The Jarisch-Herxheimer reaction complicating syphilotherapy in pregnancy. Obstet Gynecol. 1990;75(3 Pt 1):375–80.PubMedGoogle Scholar
  22. Libois A, De WS, Poll B, et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis. 2007;34:141–4.CrossRefGoogle Scholar
  23. Lukehart SA, Hook III EW, Baker-Zander SA, et al. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med. 1988;109:855–62.CrossRefGoogle Scholar
  24. Lukehart SA, Godornes C, Molini BJ, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med. 2004;351:154–8.CrossRefGoogle Scholar
  25. Marra CM, Boutin P, McArthur JC, et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis. 2000;30:540–4.CrossRefGoogle Scholar
  26. Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis. 2004a;189:369–76.CrossRefGoogle Scholar
  27. Marra CM, Maxwell CL, Tantalo L, et al. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis. 2004b;38:1001–6.CrossRefGoogle Scholar
  28. Marra CM, Maxwell CL, Tantalo LC, et al. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis. 2008;47:893–9.CrossRefGoogle Scholar
  29. Mitchell SJ, Engelman J, Kent CK, et al. Azithromycin-resistant syphilis infection: San Francisco, California, 2000–2004. Clin Infect Dis. 2006;42:337–45.CrossRefGoogle Scholar
  30. Nandwani R, Evans DT. Are you sure it’s syphilis? A review of false positive serology. Int J STD AIDS. 1995;6:241–8.CrossRefGoogle Scholar
  31. Pope V. Use of treponemal tests to screen for syphilis. Infect Med. 2004;21:399–402.Google Scholar
  32. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med. 2005;353:1236–44.CrossRefGoogle Scholar
  33. Rolfs RT, Joesoef MR, Hendershot EF, et al; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med. 1997;337:307–14.Google Scholar
  34. Romanowski B, Sutherland R, Fick GH, et al. Serologic response to treatment of infectious syphilis. Ann Intern Med. 1991;114:1005–9.CrossRefGoogle Scholar
  35. Shann S, Wilson J. Treatment of neurosyphilis with ceftriaxone. Sex Transm Infect. 2003;79:415–6.CrossRefGoogle Scholar
  36. Smith NH, Musher DM, Huang DB, et al. Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS. 2004;15:328–32.CrossRefGoogle Scholar
  37. Su JR, Hook E, Kenney K, et al. Prevalence of the 23S rRNA point mutation in Treponema pallidum in the United States and associated factors, 2006–2008. In: 18th International Society for Sexually Transmitted Diseases Research, London, #OS1.11.03. 2009.Google Scholar
  38. Walker GJ. Antibiotics for syphilis diagnosed during pregnancy. Cochrane Database Syst Rev. 2001:(3);CD001143.Google Scholar
  39. Wendel Jr GD, Sheffield JS, Hollier LM, et al. Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clin Infect Dis. 2002;35 Suppl 2:S200–9.CrossRefGoogle Scholar
  40. Wong T, Singh AE, De P. Primary syphilis: serological treatment response to doxycycline/tetracycline versus benzathine penicillin. Am J Med. 2008;121:903–8.CrossRefGoogle Scholar
  41. World Health Organization. The global elimination of congenital syphilis: rationale and strategy for action. Geneva: WHO Department of Reproductive Health and Research; 2005.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Department of Sexual HealthPhysician Emeritus General Infirmary Leeds, Leeds Teaching HospitalsLeedsUK

Personalised recommendations